JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs
- Project number: LSC20-004
- Project Management: Dagmar Stoiber-Sakaguchi, Karl Landsteiner University for Health Sciences / Department of Pharmacology
- Project partner(s): Karl Landsteiner University for Health Sciences / Clinical Department of Internal Medicine 2 (UK Krems), Karl Landsteiner Private University for Health Sciences / Molecular Haematology / Oncology, University of Veterinary Medicine Vienna / Institute of Pharmacology and Toxicology
- Project duration: 36 months from 1 January 2022
Univ.-Prof. PD MMag. Dr. Dagmar Stoiber-Sakaguchi
Head of
Department of Pharmacology
OA Univ.-Prof. Mag. DDr. Klaus Podar
Head of
Department of Molecular Oncology and Hematology, Division of Internal Medicine 2 (University Hospital Krems)